Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Celgene revenue increased from $13 billion in 2017 to $15.3 billion in 2018, a (17.5%) increase.
Annual Revenue ($)
Celgene revenue was $15.28 b in FY, 2018 which is a (17.5%) year over year increase from the previous period.
Quarterly Revenue ($)
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Geographic Segment
Celgene revenue breakdown by business segment: 10.5% from Inflammation & Immunology, 89.4% from Hematology / Oncology and 0.1% from Other
Celgene revenue breakdown by geographic segment: 65.6% from U.S. and 34.4% from International
| FY, 2017 | FY, 2018 | FY, 2016 | |
|---|---|---|---|
| Inflammation & Immunology | $1.28 b | $1.61 b | $1.02 b |
| Other revenue | $30 m | $16 m | $44 m |
| Hematology / Oncology | $11.69 b | $13.66 b | $10.17 b |
| FY, 2017 | FY, 2018 | FY, 2016 | |
|---|---|---|---|
| U.S. | $8.32 b | $10.02 b | $7.01 b |
| Europe | $3.33 b | $3.05 b | |
| All other | $1.35 b | $1.17 b | |
| International | $5.25 b |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.